Potential SP Valuation of AT1 - 80 cents to 1.30/share, page-18

Thanks dguru. You make a very important point about AT1 Management not being greedy. When asked about potential for price increase, CEO response was now is not the time given the severity of the COVID 19 pandemic globally. he then talks about running the business ethically.

This comment is at the end of the Eureka interview.

At a time where most companies trying to make money or raise capital at any cost, Atomo is setting a good example. This is why this business is backed by the Gates Foundation through Global Health Investment Fund.Before they did the equity injection, The Gates Foundation had given them grants in the past.

What I like about Atomo is it has long term sustainable revenue streams. COVID 19 test kit was an unplanned business opportunity.

They have a good business model and have great partnerships. For example, Mylan is a USD 11.5bn revenue business listed on NASDAQ selling AT1 HIV test kits.